Postprocedural endocrine and metabolic disorders, not elsewhere classified

MESH PheWeb

E4_ENDOMETPOSTOP

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 E89

Hospital discharge: ICD-9 2440|2513|2562|2572|24409

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 E89

Cause of death: ICD-9 2440|2513|2562|2572|24409

Cause of death: ICD-8 $!$

KELA reimbursements: KELA codes ANY

KELA reimbursements: ICD-10 E89.4, E89.5

164428

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

2515

Check minimum number of events None

2515

Include endpoints None

2515

E4_ENDOMETPOSTOP

Extra metadata

Level in the ICD hierarchy 4

First used in FinnGen datafreeze DF2

Parent code in ICD-10 E70-E90

Name in latin Perturbationes endocrinae et metabolicae post interventiones non alibi classificatae

Similar endpoints

↥

List of similar endpoints to Postprocedural endocrine and metabolic disorders, not elsewhere classified based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	2412	1939	473
Unadjusted prevalence (%)	0.78	1.12	0.35
Mean age at first event (years)	52.64	52.23	54.31

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	0.06	5.17 [3.79, 7.04]	2.2e-25	122
15 years	0.01	2.31 [1.63, 3.28]	2.8e-6	50
5 years	0.00	4.38 [2.90, 6.63]	2.6e-12	44
1 year	0.00	6.42 [3.40, 12.11]	9.7e-9	14

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: E4_ENDOMETPOSTOP – Postprocedural endocrine and metabolic disorders, not elsewhere classified
GWS hits: 1

Survival analyses between endpoints

↥

Plot

before Postprocedural endocrine and metabolic disorders, not elsewhere classified
after Postprocedural endocrine and metabolic disorders, not elsewhere classified

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Postprocedural endocrine and metabolic disorders, not elsewhere classified

↥